Celltrion chairman\
Scope
Date
~
-
BioCelltrion founder aims to raise $1 bn for healthcare startup from global funds
Seo Jung-jin, founder and chairman of South Korea’s biosimilar maker Celltrion Group, said on Oct. 6 that he is in talks with a number of global...
Oct 07, 2020 (Gmt+09:00)
-
BioCelltrion group tipped to exceed 1 trillion won in profit; first among bio firms
South Korea’s Celltrion Inc. and its affiliates are expected to post robust operating profits this year on the back of strong sales of Remsima a...
Sep 15, 2020 (Gmt+09:00)
-
CelltrionCelltrion rebuts JP Morgan’s heavy downgrade; shares rebound from sharp fall
South Korea’s Celltrion Inc. on Sept. 10 rebutted J.P. Morgan’s massive downgrade of its target price for the biopharmaceutical company. T...
Sep 10, 2020 (Gmt+09:00)
-
BioCelltrion to co-develop pill-type autoimmune disease drug with UK startup
Biosimilar maker Celltrion Inc. has agreed to develop a tablet-type treatment for autoimmune diseases jointly with the UK biotech startup Intract Phar...
Aug 20, 2020 (Gmt+09:00)
-
Private equityOne Equity Partners fully exits from Celltrion with $1.8 bn in proceeds
One Equity Partners (OEP), a New York based private equity firm, unloaded its remaining shares in Celltrion Healthcare valued at approximately 31...
Jul 07, 2020 (Gmt+09:00)
-
TPG picks son of ex-Samsung vice chairman to lead Korea investment
TPG named Sanghoon Lee, an ex-Morgan Stanley executive and elder son of a former Samsung Electronics vice chairman and CEO, as the head of its South K...
Aug 25, 2016 (Gmt+09:00)
Latest News
- 1 Coupang bids for Korean luxury market dominance with Farfetch
- 2 Hyundai Rotem set to finalize $6 bn K2 tank order from Poland
- 3 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 4 Korea to allow non-profits to buy bad consumer loans
- 5 LG to drive future growth in emerging markets with battery prowess
